Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

PURPOSE: On the basis of the ACCORD trial, FOLFIRINOX is effective in metastatic pancreatic adenocarcinoma (PDAC), making it a rational choice for locally advanced PDAC (LA). Aims of this study are to evaluate the accuracy of imaging in determining the resectability of PDAC and to determine the surg...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Surg
Prif Awduron: Ferrone, Cristina R., Marchegiani, Giovanni, Hong, Theodore S., Ryan, David P., Deshpande, Vikram, McDonnell, Erin I., Sabbatino, Francesco, Santos, Daniela Dias, Allen, Jill N., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Faris, Jason E., Goyal, Lipika, Kwak, Eunice L., Murphy, Janet E., Ting, David T., Wo, Jennifer Y., Zhu, Andrew X., Warshaw, Andrew L., Lillemoe, Keith D., Castillo, Carlos Fernández-del
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349683/
https://ncbi.nlm.nih.gov/pubmed/25599322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000000867
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg